SEC Tracker
Get the app

Passage BIO PASG

Passage Bio to merge with Remix

Securities offering

Form
424B3
Filed
Importance
Routine
  1. Merger with Remix Therapeutics, Inc.
  2. Passage Bio to change name to Remix Therapeutics, Inc.
  3. Exchange ratio of 0.1727 shares of Passage Bio for each Remix share
  4. Concurrent financing of $100 million expected

Written from the 424B3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Passage BIO files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Pulmatrix PULM public float $25M, Jun 30, 2025
  2. Scynexis SCYX public float $26M, Jun 30, 2025
  3. Palatin Technologies PTN public float $26M, Dec 31, 2025
  4. Curis CRIS public float $25M, Jun 30, 2025
  5. Kala Bio KALA public float $25M, Jun 30, 2025